Medtronic Corevalve, LLC v. Edwards Lifesciences Corp., No. 13-1117 (Fed. Cir. Jan. 22, 2014)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Medtronic CoreValve, LLC, the assignee of U.S. P a- tent No. 7,892,281 (“’281 patent”), appeals from the jud g- ment of the United States District Court for the Central District of California granting summary judgment to Edwards Lifesciences Corp., Edwards Lifesciences LLC, and Edwards Lifesciences (U.S.) Inc. (collectively, “E d- wards”) of invalidity of c ertain claims of the ’281 patent. The judgment rests on the district court’s grant of partial summary judgment that the ’281 patent is limited to a priority date of no earlier than April 10, 2003 .